Literature DB >> 15118843

18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET.

Tarik Belhocine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118843     DOI: 10.1007/s00259-004-1547-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

1.  Detection of alterations in brain glucose metabolism by positron emission tomography in Takayasu's arteritis.

Authors:  Stefan M Weiner; Peter Vaith; Ulrich A Walker; Ingo Brink
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

Review 2.  18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective.

Authors:  M Schirmer; K T Calamia; M Wenger; A Klauser; C Salvarani; R Moncayo
Journal:  Exp Gerontol       Date:  2003-04       Impact factor: 4.032

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

4.  Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus.

Authors:  S M Weiner; A Otte; M Schumacher; I Brink; F D Juengling; T Sobanksi; E U Nitzsche; H H Peter
Journal:  Lupus       Date:  2000       Impact factor: 2.911

5.  Neuro-Behçet's syndrome in a patient not fulfilling criteria for Behçet's disease: clinical features and value of brain imaging.

Authors:  S M Weiner; A Otte; M Schumacher; F D Juengling; I Brink; E U Nitzsche; H H Peter; W Kreisel
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

6.  PET and MR imaging in a neuro-Behçet syndrome.

Authors:  K Wildhagen; G J Meyer; G Stoppe; P Heintz; H Deicher; H Hundeshagen
Journal:  Eur J Nucl Med       Date:  1989

7.  New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.

Authors:  D Blockmans; A Maes; S Stroobants; J Nuyts; G Bormans; D Knockaert; H Bobbaers; L Mortelmans
Journal:  Rheumatology (Oxford)       Date:  1999-05       Impact factor: 7.580

Review 8.  Clinical application of positron emission tomography for diagnosis of dementia.

Authors:  Kazunari Ishii
Journal:  Ann Nucl Med       Date:  2002-12       Impact factor: 2.668

Review 9.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors:  Hongming Zhuang; Abass Alavi
Journal:  Semin Nucl Med       Date:  2002-01       Impact factor: 4.446

10.  Cerebral lesions incidentally detected on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography images of patients evaluated for body malignancies.

Authors:  Vinicius Ludwig; Tsuyoshi Komori; David Kolb; William H Martin; Martin P Sandler; Dominique Delbeke
Journal:  Mol Imaging Biol       Date:  2002-10       Impact factor: 3.488

View more
  1 in total

1.  18F-fluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin.

Authors:  Karel-Jan D F Lensen; Alexandre E Voskuyl; Conny J van der Laken; Emile F I Comans; Dirkjan van Schaardenburg; Alex B Arntzenius; Ton Zwijnenburg; Frank Stam; Michelle Gompelman; Friso M V D Zant; Anneke Q A van Paassen; Bert J Voerman; Frits Smit; Sander Anten; Carl E Siegert; Arjen Binnerts; Yvo M Smulders
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.